In today’s economic environment, even the most innovative life science companies are forced to make hard decisions, such as downsizing teams, consolidating operations or pausing ambitious growth plans.
While these transitions are challenging, they also open the door to new ways of working such as leaner, more focused and more collaborative environments. That’s where the Pennsylvania Biotechnology Center (PABC) comes in.
“At the PABC, we offer more than just lab and office space,” Bob Christmas, chief operating officer said. “We provide a supportive, resource-rich environment designed specifically for life science companies looking to pivot, preserve value and position themselves for the next phase of growth.”
Whether you’re restructuring a team, spinning out a new venture or seeking a soft landing during a market reset, the PABC can help you:
Lower your fixed costs with flexible, scalable leases,
Plug into a ready-made ecosystem of CROs, investors, and peers,
Access move-in-ready lab infrastructure and shared equipment,
Get direct support from experienced biotech executives and commercialization experts,
Stay connected to the broader Philadelphia and national biotech communities without the overhead.
At the PABC, downsizing doesn’t mean disconnecting. Instead, it’s an opportunity to regroup and relaunch with purpose inside one of the nation’s most successful life sciences incubators If your company is navigating a transition and exploring its next chapter, we’d love to talk. Please visit our website.
About the Pennsylvania Biotechnology Center Nearly 100 organizations belong to the PABC, which is a nonprofit life sciences incubator and accelerator providing a collaborative ecosystem and state-of-the-art laboratory and office space. There are more than 70 early stage companies onsite at its two locations. Along with its campus in Doylestown, where a new building with labs and offices opened three years ago, the PABC operates B+labs at Cira Centre in University City, Philadelphia. B+labs, which was launched in 2022, is a partnership with Brandywine Realty Trust. The PABC uses a highly successful services-based approach to nurture and guide its member companies to success, advancing biotechnology, maximizing synergies among nonprofit scientists and their commercial colleagues, and launching new ideas and discoveries. PABC companies account for 17% of all National Institutes of Health SBIR grants awarded in Pennsylvania recently and over the years have created more than a billion dollars in market value from IPOs, acquisitions and commercial valuations. For more information, please visit the PABC website.
In today’s economic environment, even the most innovative life science companies are forced to make hard decisions, such as downsizing teams, consolidating operations or pausing ambitious growth plans.
While these transitions are challenging, they also open the door to new ways of working such as leaner, more focused and more collaborative environments. That’s where the Pennsylvania Biotechnology Center (PABC) comes in.
“At the PABC, we offer more than just lab and office space,” Bob Christmas, chief operating officer said. “We provide a supportive, resource-rich environment designed specifically for life science companies looking to pivot, preserve value and position themselves for the next phase of growth.”
Whether you’re restructuring a team, spinning out a new venture or seeking a soft landing during a market reset, the PABC can help you:
At the PABC, downsizing doesn’t mean disconnecting. Instead, it’s an opportunity to regroup and relaunch with purpose inside one of the nation’s most successful life sciences incubators If your company is navigating a transition and exploring its next chapter, we’d love to talk. Please visit our website.
About the Pennsylvania Biotechnology Center
Nearly 100 organizations belong to the PABC, which is a nonprofit life sciences incubator and accelerator providing a collaborative ecosystem and state-of-the-art laboratory and office space. There are more than 70 early stage companies onsite at its two locations. Along with its campus in Doylestown, where a new building with labs and offices opened three years ago, the PABC operates B+labs at Cira Centre in University City, Philadelphia. B+labs, which was launched in 2022, is a partnership with Brandywine Realty Trust. The PABC uses a highly successful services-based approach to nurture and guide its member companies to success, advancing biotechnology, maximizing synergies among nonprofit scientists and their commercial colleagues, and launching new ideas and discoveries. PABC companies account for 17% of all National Institutes of Health SBIR grants awarded in Pennsylvania recently and over the years have created more than a billion dollars in market value from IPOs, acquisitions and commercial valuations. For more information, please visit the PABC website.